These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9558024)

  • 1. Polymorphism of motilin gene in patients with Crohn's disease.
    Annese V; Piepoli A; Andriulli A; Napolitano G; Bisceglia L; Zelante L; Gasparini P
    Dig Dis Sci; 1998 Apr; 43(4):715-9. PubMed ID: 9558024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
    Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP
    Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease.
    Yang H; Vora DK; Targan SR; Toyoda H; Beaudet AL; Rotter JI
    Gastroenterology; 1995 Aug; 109(2):440-8. PubMed ID: 7615193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status.
    Braun C; Zahn R; Martin K; Albert E; Folwaczny C
    Clin Immunol; 2001 Dec; 101(3):357-60. PubMed ID: 11726228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
    García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
    Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
    Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity.
    Abad E; Tural C; Mirapeix E; Cuxart A
    J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).
    Bouma G; Xia B; Crusius JB; Bioque G; Koutroubakis I; Von Blomberg BM; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1996 Mar; 103(3):391-6. PubMed ID: 8608636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens.
    Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K
    Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.
    Vasiliauskas EA; Plevy SE; Landers CJ; Binder SW; Ferguson DM; Yang H; Rotter JI; Vidrich A; Targan SR
    Gastroenterology; 1996 Jun; 110(6):1810-9. PubMed ID: 8964407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients.
    Papp M; Altorjay I; Norman GL; Shums Z; Palatka K; Vitalis Z; Foldi I; Lakos G; Tumpek J; Udvardy ML; Harsfalvi J; Fischer S; Lakatos L; Kovacs A; Bene L; Molnar T; Tulassay Z; Miheller P; Veres G; Papp J; ; Lakatos PL
    Inflamm Bowel Dis; 2007 Aug; 13(8):984-92. PubMed ID: 17417801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
    Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
    Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil and pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease.
    Folwaczny C; Noehl N; Endres SP; Loeschke K; Fricke H
    Scand J Gastroenterol; 1998 May; 33(5):523-8. PubMed ID: 9648993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of ICAM-1 gene polymorphism in immunologic subsets of inflammatory bowel disease.
    Yang H
    Exp Clin Immunogenet; 1997; 14(3):214-25. PubMed ID: 9493790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
    Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
    Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease.
    Glas J; Török HP; Tonenchi L; Wetzke M; Beynon V; Teshome MY; Cotofana S; Schiemann U; Griga T; Klein W; Epplen JT; Folwaczny C; Folwaczny M; Mussack T; Weiss EH
    Int Immunol; 2007 May; 19(5):621-6. PubMed ID: 17446213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.